Back to UBS Group AG UBS Group AG

CAPRCAPR
25 quarters

Position history for UBS Group AGUBS Group AG's holdings in CAPRICOR THERAPEUTICS INC

UBS Group AG holds 619,661 shares of CAPR (CAPRICOR THERAPEUTICS INC), worth $14.9M as of 2026-Q2. The position was increased (+66.6% shares). CAPR represents 0.0% of UBS Group AG's portfolio.

Current Value

$14.9M

Current Shares

619,661

Total Value Change

+$14.9M

Total Shares Change

+619,407

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
619,661
+66.6%
$14.9M0.0%$24.08
41
2026-Q1
Increased
371,984
+56.1%
$11.3M0.0%$25.84
39
2025-Q4
Increased
238,216
+91.0%
$6.9M0.0%$28.96
43
2025-Q3
Decreased
124,717
-77.3%
$899,2100.0%$7.41
0
2025-Q2
Increased
549,427
+39.7%
$5.5M0.0%$11.15
36
2025-Q1
Increased
393,343
+220.3%
$3.7M0.0%$11.50
43
2024-Q4
Increased
122,818
+836.3%
$1.7M0.0%$13.76
41
2024-Q3
Increased
13,118
+51.0%
$199,5250.0%$9.95
22
2024-Q2
Increased
8,687
+479.1%
$41,4370.0%$4.77
22
2024-Q1
New
1,500
-
$10,1850.0%$6.79
26
2023-Q2
Exited
0
-100.0%
$00.0%$4.80
0
2023-Q1
New
4,439
-
$18,7330.0%$4.31
28
2022-Q3
Exited
0
-100.0%
$00.0%$5.93
0
2022-Q2
Increased
29,352
+326.0%
$102,0000.0%$3.76
24
2022-Q1
Increased
6,890
+83.8%
$23,0000.0%$3.45
20
2021-Q4
New
3,748
-
$11,0000.0%$3.00
26
2021-Q3
Exited
0
-100.0%
$00.0%$3.88
0
2021-Q2
Increased
1,922
+412.5%
$10,0000.0%$5.30
19
2021-Q1
Decreased
375
-92.6%
$2,0000.0%$4.62
0
2020-Q4
Increased
5,076
+167.2%
$17,0000.0%$3.70
20
2020-Q3
Increased
1,900
+90.0%
$10,0000.0%$5.41
18
2020-Q2
Decreased
1,000
-30.5%
$5,0000.0%$4.73
0
2020-Q1
Decreased
1,439
-73.4%
$2,0000.0%$1.19
0
2019-Q4
Increased
5,413
+2031.1%
$7,0000.0%$1.27
18
2019-Q3
New
254
-
$1,0000.0%$3.08
17

Other major holders of CAPR: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used